O. Scheel et al., IN-VITRO SUSCEPTIBILITY OF ISOLATES OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS 1988-1993, Journal of antimicrobial chemotherapy, 37(2), 1996, pp. 243-251
MICs for 423 strains of methicillin-resistant Staphylococcus aureus (M
RSA) isolated in Hong Kong during 1988-1993 were performed for 15 anti
microbial agents: erythromycin, chloramphenicol, tetracycline, minocyc
line, gentamicin, netilmicin, trimethoprim, rifampicin, fusidic acid,
ciprofloxacin, vancomycin, teicoplanin, sparfloxacin, clinafloxacin an
d RP 59500 (quinupristin/dalfopristin). Susceptibility to antibiotics
generally remained stable throughout the study period, with the except
ion of the quinolones. Resistance to ciprofloxacin (breakpoint 4 mg/L)
increased from a low of 9% in 1988 to a high of 82% in 1993. For spar
floxacin the corresponding figures were 9% and 78%, respectively. Six
(1%) clinafloxacin-resistant strains were found. MIC(50)s and MIC(90)s
of clinafloxacin increased from less than or equal to 0.06 mg/L and 0
.25 mg/L in 1988 to 1.0 mg/L and 2.0 mg/L, respectively, in 1993. All
423 strains were phage typed (typability 70%) and a diversity of phage
types which changed during the observation period, with 13 dominating
types, was observed. Ciprofloxacin resistance occurred in 12 of the d
ominating types, in 46 non-typable strains, and also in 23 strains of
different, sporadically occurring types, indicating that the emergence
of quinolone resistance was not due to dissemination of a single or f
ew MRSA clones. The usefulness of quinolones in the treatment of MRSA
infections is likely to be seriously constrained by the emergence of r
esistance. MICs for RP-59500 were less than or equal to 2 mg/L for all
isolates, suggesting that this agent merits further evaluation as an
anti-MRSA agent. All MRSA remained susceptible to vancomycin and teico
planin throughout the study period.